254 related articles for article (PubMed ID: 12180893)
21. Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.
Duvic M; Friedman-Kien AE; Looney DJ; Miles SA; Myskowski PL; Scadden DT; Von Roenn J; Galpin JE; Groopman J; Loewen G; Stevens V; Truglia JA; Yocum RC
Arch Dermatol; 2000 Dec; 136(12):1461-9. PubMed ID: 11115156
[TBL] [Abstract][Full Text] [Related]
22. Clinical aspects and management of AIDS-related Kaposi's sarcoma.
Levine AM; Tulpule A
Eur J Cancer; 2001 Jul; 37(10):1288-95. PubMed ID: 11423260
[TBL] [Abstract][Full Text] [Related]
23. Paclitaxel for AIDS-associated Kaposi's sarcoma.
Dhillon T; Stebbing J; Bower M
Expert Rev Anticancer Ther; 2005 Apr; 5(2):215-9. PubMed ID: 15877519
[TBL] [Abstract][Full Text] [Related]
24. Systemic treatment of Kaposi's sarcoma: current status and future directions.
Lilenbaum RC; Ratner L
AIDS; 1994 Feb; 8(2):141-51. PubMed ID: 7519018
[TBL] [Abstract][Full Text] [Related]
25. Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy.
Núñez M; Saballs P; Valencia ME; Santos J; Ferrer E; Santos I; Berrocal A; Galindo MJ; Podzamczer D; Gonzlez-Lahoz J;
HIV Clin Trials; 2001; 2(5):429-37. PubMed ID: 11673818
[TBL] [Abstract][Full Text] [Related]
26. The role of vascular endothelial growth factor (VEGF) in AIDS-related Kaposi's sarcoma.
Arastéh K; Hannah A
Oncologist; 2000; 5 Suppl 1():28-31. PubMed ID: 10804088
[TBL] [Abstract][Full Text] [Related]
27. Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations.
Stebbing J; Wildfire A; Portsmouth S; Powles T; Thirlwell C; Hewitt P; Nelson M; Patterson S; Mandalia S; Gotch F; Gazzard BG; Bower M
Ann Oncol; 2003 Nov; 14(11):1660-6. PubMed ID: 14581275
[TBL] [Abstract][Full Text] [Related]
28. Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity.
Yarchoan R; Pluda JM; Wyvill KM; Aleman K; Rodriguez-Chavez IR; Tosato G; Catanzaro AT; Steinberg SM; Little RF
Crit Rev Immunol; 2007; 27(5):401-14. PubMed ID: 18197804
[TBL] [Abstract][Full Text] [Related]
29. Kaposi's sarcoma and human chorionic gonadotropin: mechanisms, moieties and mysteries.
Bisacchi D; Noonan DM; Carlone S; Albini A; Pfeffer U
Biol Chem; 2002 Sep; 383(9):1315-20. PubMed ID: 12437123
[TBL] [Abstract][Full Text] [Related]
30. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.
Gill PS; Tulpule A; Espina BM; Cabriales S; Bresnahan J; Ilaw M; Louie S; Gustafson NF; Brown MA; Orcutt C; Winograd B; Scadden DT
J Clin Oncol; 1999 Jun; 17(6):1876-83. PubMed ID: 10561228
[TBL] [Abstract][Full Text] [Related]
31. Do we still need chemotherapy for AIDS-associated Kaposi's sarcoma?
Dalla Pria A; Hayward K; Bower M
Expert Rev Anticancer Ther; 2013 Feb; 13(2):203-9. PubMed ID: 23406561
[TBL] [Abstract][Full Text] [Related]
32. Thalidomide in the treatment of Kaposi's sarcoma.
Rubegni P; Sbano P; De Aloe G; Flori ML; Fimiani M
Dermatology; 2007; 215(3):240-4. PubMed ID: 17823523
[TBL] [Abstract][Full Text] [Related]
33. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy.
Hengge UR; Ruzicka T; Tyring SK; Stuschke M; Roggendorf M; Schwartz RA; Seeber S
Lancet Infect Dis; 2002 May; 2(5):281-92. PubMed ID: 12062994
[TBL] [Abstract][Full Text] [Related]
34. Paclitaxel for treating KS.
Proj Inf Perspect; 1997 Nov; (23):15. PubMed ID: 11365372
[TBL] [Abstract][Full Text] [Related]
35. New drug targets in Kaposi sarcoma.
Sullivan RJ; Pantanowitz L
Expert Opin Ther Targets; 2010 Dec; 14(12):1355-66. PubMed ID: 21043836
[TBL] [Abstract][Full Text] [Related]
36. Treatment of Kaposi's sarcoma. Current guidelines and future perspectives.
Northfelt DW
Drugs; 1994 Oct; 48(4):569-82. PubMed ID: 7528130
[TBL] [Abstract][Full Text] [Related]
37. Oral HIV-associated Kaposi sarcoma.
Pantanowitz L; Khammissa RA; Lemmer J; Feller L
J Oral Pathol Med; 2013 Mar; 42(3):201-7. PubMed ID: 22672182
[TBL] [Abstract][Full Text] [Related]
38. Treatment of Kaposi's sarcoma in HIV-1 infected individuals with emphasis on resource poor settings.
Dedicoat M; Vaithilingum M; Newton R
Cochrane Database Syst Rev; 2003; (3):CD003256. PubMed ID: 12917957
[TBL] [Abstract][Full Text] [Related]
39. Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma.
Tulpule A; Scadden DT; Espina BM; Cabriales S; Howard W; Shea K; Gill PS
J Clin Oncol; 2000 Feb; 18(4):716-23. PubMed ID: 10673512
[TBL] [Abstract][Full Text] [Related]
40. Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team.
Dezube BJ; Von Roenn JH; Holden-Wiltse J; Cheung TW; Remick SC; Cooley TP; Moore J; Sommadossi JP; Shriver SL; Suckow CW; Gill PS
J Clin Oncol; 1998 Apr; 16(4):1444-9. PubMed ID: 9552050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]